Graphite Bio Competitors and Similar CompaniesClear all
Graphite Bio's competitors and similar companies include ProQR Therapeutics.
 Graphite Bio Graphite Bio is a gene-editing company focused on the development of therapies for patients suffering from life-threatening genetic diseases. |  ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases. | |
Founding Date | Founding Date 2017 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Leiden, NL HQ Cambridge, US |
Employees | Employees 27 | Employees 166 |
Valuation ($) | Valuation ($) 185.2 m | Valuation ($) 281.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $19.1m (FY, 2025) | Revenue (est.) €15.9m (FY, 2025) |
Cost of goods | Cost of goods $418k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $18.7m (FY, 2025) | Gross profit €16.3m (FY, 2025) |
Net income | Net income ($82.1m) (FY, 2025) | Net income (€42.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
ProQR Therapeutics
HQ
Leiden, NL
Employees
166
ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
View company